SQZ Biotechnologies (NYSE:SQZ – Get Free Report) and Precision BioSciences (NASDAQ:DTIL – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast ...

Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, today announced ...

Transactions Senior Resource Group acquires Atria community Senior Resource Group announced it has acquired Atria Mt. Pleasant, a retirement community ...

Arcus Biosciences Inc . (NYSE:RCUS) stock has reached a 52-week low, touching down at $13.48. This latest price movement ...

Hayward, CA-based Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage biopharmaceutical company with a market ...

Arcus Biosciences named former Amgen executive Richard Markus as its chief medical officer. The biopharmaceutical company, which is focused on cancer treatments, said Tuesday that Markus is scheduled ...

Arcus Biosciences (RCUS) announced that Richard Markus, M.D., Ph.D., has been appointed chief medical officer effective January 31, 2025. Dr.

Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated ...

According to the Euro News report, the American National Guard will deploy 8000 service members from 40 states during the ...

Donald Trump's looking to keep his supporters safe on Inauguration Day ... moving Monday's events indoors 'cause it's freezing in the nation's capital -- after the country dropped a bag ...

Donald Trump's inauguration ceremony is relying on a private security company ... and Uncle Sam is paying a pretty penny to keep the incoming President safe.

Barclays analyst Peter Lawson maintained a Buy rating on Arcus Biosciences (RCUS – Research Report) today and set a price target of $29.00. The ...